Regulatory Updates

State: All

Date Proposed : 06/8/2021

Program: Home Infusion Therapy

To establish a demonstration program to provide integrated care for Medicare beneficiaries with end-stage renal disease, and for other purposes. US H 4942

State: All

Date Proposed : 12/10/2020

Program: Renal Dialysis

MLN fact sheet in reference to Hospice Aide Services: Enhancing RN supervision.

State: All

Program: Renal Dialysis

Under Article Text added Documentation Requirements section and corresponding verbiage and revised verbiage in #4 to read “The medical record documentation must support the medical necessity of the services as stated in the related policy”

State: All

Date Proposed : 10/5/2020

Program: Hospice

Extraordinary Circumstances as Related to Hospice Staffing Requirements: A hospice may use contracted staff, if necessary, to supplement hospice employees in order to meet the needs of patients under extraordinary or other non-routine circumstances. The regulation allows the hospice to utilize these services temporarily without a waiver or exemption from the State Survey Agency (SA) or the CMS Location.

State: All

Date Proposed : 11/6/2020

Date Effective : 10/1/2020

Program: Hospice

The Centers for Medicare & Medicaid Services (CMS) is making changes to the Medicare Benefit Policy Manual to include the modifications to the election statement and the requirements for the hospice election statement addendum, effective for hospice elections beginning on or after October 1, 2020.

State: All

Date Proposed : 10/1/2020

Program: Pharmacy

We are pleased to have reached this important milestone and continue our collaborative efforts with states and other stakeholders to protect patients from the potential risks associated with poor quality compounded drugs, while ensuring appropriate access to compounded drugs for patients that have a medical need for them. The availability of our standard memorandum of understanding (MOU) for signature by the states will help enhance communication and maximize our federal and state resources for oversight of compounded drugs produced by traditional compounding pharmacies.